20 LATEST RESOURCES (91 INDEXED)
A Multicenter, Single-Arm, Open-Label Interventional Study of Adherence to Brexpiprazole during Switching from Previous Antipsychotic Drugs in Patients with Schizophrenia or Schizoaffective Disorder · January 2024
Articles
Neuropsychopharmacology Reports
Comparison of Brexpiprazole, Aripiprazole, and Placebo for Japanese Major Depressive Disorder: A Systematic Review and Network Meta-Analysis · January 2024
Articles
Neuropsychopharmacology Reports
Brexpiprazole versus Placebo or Other Antidepressive Agents for Treating Depression · July 2023
Abstracts
Cochrane Database of Systematic Reviews
Can Brexpiprazole Be Switched Safely in Patients with Schizophrenia and Dopamine Supersensitivity Psychosis? A Retrospective Analysis in a Real-World Clinical Practice · July 2023
Abstracts
Journal of Psychopharmacology
Subjective Assessment of Brexpiprazole in Patients with Schizophrenia: A Prospective Observational Study · May 2023
Articles
Fujita Medical Journal
Effects of Adjunctive Brexpiprazole on Patient Life Engagement in Major Depressive Disorder: Post Hoc Analysis of Inventory of Depressive Symptomatology Self-Report Data · April 2023
Articles
Journal of Psychiatric Research
An Exploratory Database Study of Factors Influencing the Continuation of Brexpiprazole Treatment (Prescription) in Patients with Schizophrenia Using Information from Psychiatric Electronic Medical Records Processed with Natural Language Processing · March 2023
Articles
Schizophrenia Research
Life Engagement Improvement Following Initiation of Brexpiprazole Treatment in Patients with MDD: A Naturalistic, Retrospective Real-World Study · March 2023
Articles
ClinicoEconomics and Outcomes Research
Brexpiprazole-Pharmacologic Properties and Use in Schizophrenia and Mood Disorders · February 2023
Articles
Brain Sciences
Analysis of the Effect of Brexpiprazole on Sleep Architecture in Patients with Schizophrenia: A Preliminary Study · January 2023
Articles
Neuropsychopharmacology Reports
The Use of Brexpiprazole Combined with a Stimulant in Adults with Treatment-Resistant Attention-Deficit/Hyperactivity Disorder · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials · August 2022
Articles
Neuropsychiatric Disease and Treatment
Efficacy of Brexpiprazole for Treatment Persistent Negative Symptoms in Three Schizophrenic Patients: A Case Series · August 2022
Articles
Psychiatry Research Case Reports
Brexpiprazole as a New Approach of Treatment in Somatization Disorder · January 2022
Articles
Emerging Trends in Drugs, Addictions, and Health
A Double-Blind Placebo-Controlled Study of Brexpiprazole for the Treatment of Borderline Personality Disorder · November 2021
Articles
British Journal of Psychiatry
Effects of Brexpiprazole Across Symptom Domains in Patients with Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies · May 2021
Articles
Schizophrenia Bulletin Open
Continuation Rate for Asenapine and Brexpiprazole Treatment in Patients with Schizophrenia · March 2021
Articles
Brain and Behavior
Two Randomized, Double-Blind, Placebo-Controlled Trials and One Open-Label, Long-Term Trial of Brexpiprazole for the Acute Treatment of Bipolar Mania · March 2021
Articles
Journal of Psychopharmacology
Safety of Switching to Brexpiprazole in Japanese Patients with Schizophrenia: A Post‐Hoc Analysis of a Long‐Term Open‐Label Study · January 2021
Articles
Human Psychopharmacology: Clinical and Experimental
Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics Brexpiprazole, Lurasidone, Asenapine, Cariprazine, and Iloperidone with Olanzapine as a Comparator · January 2021
Abstracts
Journal of Clinical Psychopharmacology